131 related articles for article (PubMed ID: 31804677)
1. Analysis of CASP12 diagnostic and prognostic values in cervical cancer based on TCGA database.
Feng G; Beilei Z; Caizhi C; Wen Z
Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31804677
[TBL] [Abstract][Full Text] [Related]
2. The Role of High-Risk Human Papillomavirus-Related Long Non-Coding RNAs in the Prognosis of Cervical Squamous Cell Carcinoma.
Cheng Y; Yang S; Shen Y; Ding B; Wu W; Zhang Y; Liang G
DNA Cell Biol; 2020 Apr; 39(4):645-653. PubMed ID: 32045269
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of ADAMTS18 May Serve as a Poor Prognostic Biomarker for Cervical Cancer Patients.
Zhang L; Liu Y; Zheng P
Appl Immunohistochem Mol Morphol; 2018 Oct; 26(9):670-675. PubMed ID: 28362704
[TBL] [Abstract][Full Text] [Related]
4. High Expression of CCDC34 Is Associated with Poor Survival in Cervical Cancer Patients.
Liu LB; Huang J; Zhong JP; Ye GL; Xue L; Zhou MH; Huang G; Li SJ
Med Sci Monit; 2018 Nov; 24():8383-8390. PubMed ID: 30458457
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma.
Zeng YL; Guo ZY; Su HZ; Zhong FD; Jiang KQ; Yuan GD
World J Gastroenterol; 2019 Dec; 25(48):6902-6915. PubMed ID: 31908394
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
Luo M; Shen D; Wang W; Xian J
Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
[TBL] [Abstract][Full Text] [Related]
7. Expression levels of resistant genes affect cervical cancer prognosis.
Yang F; Gao B; Li R; Li W; Chen W; Yu Z; Zhang J
Mol Med Rep; 2017 May; 15(5):2802-2806. PubMed ID: 28447725
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of
Wang Q; Zheng W
Biomed Res Int; 2021; 2021():6663367. PubMed ID: 33763482
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of miR-329-3p is associated with worse prognosis in patients with cervical cancer.
Chang YH; Yin F; Fan GF; Zhao M
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4045-4049. PubMed ID: 29028098
[TBL] [Abstract][Full Text] [Related]
10. The expression and prognostic value of protein tyrosine kinase 6 in early-stage cervical squamous cell cancer.
Wang XJ; Xiong Y; Ma ZB; Xia JC; Li YF
Chin J Cancer; 2016 Jun; 35(1):54. PubMed ID: 27311570
[TBL] [Abstract][Full Text] [Related]
11. Serum Actinin-4 Levels as a Potential Diagnostic and Prognostic Marker in Cervical Cancer.
Ma X; Xue H; Zhong J; Feng B; Zuo Y
Dis Markers; 2020; 2020():5327378. PubMed ID: 32855746
[TBL] [Abstract][Full Text] [Related]
12. microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer.
Park S; Kim J; Eom K; Oh S; Kim S; Kim G; Ahn S; Park KH; Chung D; Lee H
BMC Cancer; 2019 May; 19(1):419. PubMed ID: 31060525
[TBL] [Abstract][Full Text] [Related]
13. No relationship is indicated between FHIT expression and clinicopathologic prognostic parameters in early stage cervical carcinoma.
Baykal C; Ayhan A; Al A; Yüce K; Ayhan A
Int J Gynecol Cancer; 2003; 13(2):192-6. PubMed ID: 12657123
[TBL] [Abstract][Full Text] [Related]
14. Clusterin expression predicts survival of invasive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy.
Watari H; Ohta Y; Hassan MK; Xiong Y; Tanaka S; Sakuragi N
Gynecol Oncol; 2008 Mar; 108(3):527-32. PubMed ID: 18177691
[TBL] [Abstract][Full Text] [Related]
15. Fyn-related kinase expression predicts favorable prognosis in patients with cervical cancer and suppresses malignant progression by regulating migration and invasion.
Zhang X; Li F; Zhu PL
Biomed Pharmacother; 2016 Dec; 84():270-276. PubMed ID: 27665472
[TBL] [Abstract][Full Text] [Related]
16. An 8‑gene signature predicts the prognosis of cervical cancer following radiotherapy.
Xie F; Dong D; Du N; Guo L; Ni W; Yuan H; Zhang N; Jie J; Liu G; Tai G
Mol Med Rep; 2019 Oct; 20(4):2990-3002. PubMed ID: 31432147
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of RIPK4 Predicts Poor Prognosis and Promotes Metastasis in Ovarian Cancer.
Liu S; He L; Sheng C; Su R; Wu X; Sun Y; Xi X
Biomed Res Int; 2021; 2021():6622439. PubMed ID: 34124253
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA expression in cervical cancer: Novel diagnostic and prognostic biomarkers.
Gao C; Zhou C; Zhuang J; Liu L; Liu C; Li H; Liu G; Wei J; Sun C
J Cell Biochem; 2018 Aug; 119(8):7080-7090. PubMed ID: 29737570
[TBL] [Abstract][Full Text] [Related]
19. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the prognostic significance of nm23/NDP kinase protein expression in cervical carcinoma: an immunohistochemical study.
Kristensen GB; Holm R; Abeler VM; Tropé CG
Gynecol Oncol; 1996 Jun; 61(3):378-83. PubMed ID: 8641619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
